Related Experiment Video
Updated: May 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Hormone therapy in prostate cancer.
Geoffrey M Currie1, Matthew Haase, Rashid Hashmi
1Faculty of Science, Charles Sturt University, Wagga Wagga, New South Wales, Australia. gcurrie@csu.edu.au
Nuclear medicine bone scans help monitor prostate cancer treatment response. Timely hormone therapy showed significant skeletal improvement in a patient with widespread bone metastasis.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Nuclear medicine bone scanning is a standard diagnostic tool for prostate cancer.
- Prostate cancer management involves monitoring treatment efficacy, especially in metastatic disease.
Observation:
- A case study of incidental prostate cancer diagnosis.
- Evaluation of nonspecific symptoms leading to diagnosis.
- Monitoring response to hormone therapy in advanced prostate cancer.
Findings:
- Bone scanning demonstrates significant global skeletal response to hormone therapy.
- Highlights the efficacy of timely hormone therapy for high-grade prostate cancer with widespread bony metastasis.
- Details the available hormone therapies for metastatic prostate cancer.
Implications:
- Bone scanning is crucial for monitoring treatment efficacy in metastatic prostate cancer.
- Early intervention with hormone therapy can lead to significant positive outcomes.
- Underscores the importance of considering prostate cancer in patients with nonspecific symptoms.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Tumor Immunotherapy

